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Evaluation of self-medication prevalence, 
diagnosis and prescription in migraine 
in Kerman, Iran
Behnaz Sedighi, MD, Siavash Ghaderi-Sohi, MD,  Sara Emami, MD.
Migraine is a chronic illness with a 10% average prevalence.1  Despite producing no permanent 
disturbance in most cases, it has significant effects on
the quality of life. Studies show that 4 - 7 working 
days are lost by a migraine patient in a year.2 
The efficacy of most available drugs, despite of
laboratory achievements, is not more than 70-75%.3,4 
However, some of these drugs can be 100% effective 
if they are prescribed and used correctly.4 The most 
important factor for inefficiency of treatments is the
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noncompliance of patients.4-6 Approximately 20% of 
patients do not even fill their prescriptions7 and if they 
do so, in 10-90% of them, secondary noncompliance is 
observed.8 Unfamiliarity of the physicians, especially 
general practitioners (GPs), regarding all aspects of 
migraine diagnosis, and treatment, may be mentioned 
as the basic reason for the patients  ʼself-medication;9 
consequently, side-effects, drug dependency and 
useless costs ensue.6-10  
Objective: To investigate different diagnosis aspects, 
prescribed drugs and self-medications of migraine in Iran.
Methods:  We selected 210 migraineurs from high school 
and university students in Kerman, Iran over a period of 
6 months in 2002 by multistage randomized screening 
based on the International Headache Society criteria. 
We classified them into 2 groups on the basis of whether
they had consulted a physician or not. We then evaluated 
the physician prescriptions, and prevalence of self-
medications.
Results:  Only 49% of migraineurs consulted a physician, 
and only 53% were correctly diagnosed by physicians 
according to the International Headache Society criteria. 
Our study shows that 69% of general practitioners diagnoses 
were wrong. In spite of indications for prophylactic 
ABSTRACT
treatment, it was not prescribed in 76% of the patients, 
and 50% of the general practitioners prescribed it without 
any indications. Furthermore, 91% of patients used self-
medication; Acetaminophen and Codeine were the most 
common.
Conclusion: General practitioners  ʼ misdiagnosis and 
mismanagement of the migraineurs, and easy access 
to various drugs in Iran, have led to a high rate of self-
medication. Self-medication with Codeine, with regard to 
its side effects, such as increase of secondary headaches and 
dependency is the major problem. Consequently, medical 
education systems, physician reevaluating methods, and 
the concept of self-medication among patients have to be 
revised.
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Since there is a world-wide lack of authoritative 
studies regarding self-medication and the reasons for 
noncompliance in migraine,10 we performed this study 
to investigate different diagnosis aspects, prescribed 
drugs and self-medications in Iran.
Methods. In 2002, 4521 high school and 
university students were screened by multi-stage 
randomized sampling in Kerman. This sampling 
community was selected as migraine attacks begin 
at adolescence, and in 80% of occasions before 30 
years old.1  They were screened under the supervision 
of a neurologist; and those who had migraine 
according to the International Headache Society 
(IHS) criteria11 were selected whether or not they 
had previously visited physicians and whether or not 
they had previous migraine diagnosis. Cases with any 
systemic diseases and any other reason for headache 
were excluded according to IHS criteria. The patients 
were then divided into 2 groups based on their 
previous physician consultation. For  the group who 
had previous consulted a physician, variables such 
as the probable self-medications before consulting 
a physician, compatibility of physician diagnosis 
with IHS criteria, prescribed drugs for attacks and 
prophylaxis, self-medication after consulting a 
physician, and other alternative medicines were 
evaluated. In patients without previous physician 
consultation, all mentioned variables, except those 
related to consulting a physician, were evaluated.
Regarding the probability of forgetting the 
consumed drugs (recall bias), a list of all possible 
drugs, which could have been consumed in migraine, 
had been prepared beforehand to show to the patients 
at the time of interview if needed. In this study, any 
drug consumption without prescription, before or 
after consultation, was considered self-medication, 
and patients with the diagnosis of migraine according 
to IHS criteria who visited a physician and were not 
diagnosed as migraine were considered as wrong 
diagnoses. 
Results.  We found 210 migraineurs (79 men, 131 
women) with mean age of 19 years (14-30 years). 
Among them, 103 patients (49.5%) had consulted 
physicians regarding the attacks. The mean age of 
these patients was high (p=0.00). Consultation with 
physicians had no significant difference between the
gender (p=0.7). Fifty-six percent of patients visited a 
neurologist, 28% visited a GP, and the remaining 12% 
visited other specialists. Only 53% of the patients 
who consulted a physician were correctly diagnosed 
according to IHS criteria. Diagnosis of 69% of GPs 
was wrong and only 72% of neurologists had the 
correct diagnosis.
Special drugs were prescribed for the attacks 
in 81 patients and prophylaxis in 52 patients. In 5 
(10%) patients in which prophylactic treatment was 
prescribed, there was no indication for it, while 39 
of patients that had indication according to IHS 
criteria, it was not prescribed. Only 50% of GPs and 
93% of neurologist correctly prescribed prophylactic 
treatment (p=0.01). Propranolol was prescribed for 
42 patients as prophylactic treatment. In 21%, the 
prescribed dose was less than 20 mg. Ergotamine was 
prescribed in 21 patients while in 81% the consuming 
method that was advised was wrong. Codeine was 
prescribed for 44 patients (43%). Other prescribed 
drugs for severe attacks and prophylaxis are presented 
in Table 1.
There were 107 patients (50.5%) who did not visit 
any physician, and 73 of them declared availability of 
the drugs as the main reason.  One hundred and ninety-
two patients (91%) had used self-medication. This was 
observed in 90% of patients who visited a physician 
and 93% of those who had not visited a physician. 
There was no significant difference between the 2
groups (p>0.05). The 2 most commonly consumed 
drugs as self-medications were Acetaminophen and 
Codeine (Table 1). Except for a patient that was 
consuming propranolol daily, self-medication was in 
the form of drug consumption for each attack (Table 
1). Only 8 patients did not take any drugs and only 10 
consumed just the prescribed drugs by the physician.
Alternative medicine was used by 69 patients and 
34 were in the group who visited a physician, and 35 
in the other group. Herbal therapy was used in 74% of 
patients and local materials in 22% while only 3% used 
yoga and 1% used meditation. Finally, 51% believed 
that migraine attacks are uncontrollable while 12.5% 
had no idea. However, their belief did not have any 
influence on consulting a physician (p=0.76).
Discussion.  In our study, only 50% of migraine 
patients had visited a physician. This rate is equivalent 
to the 51% acquired by Caro et al,12 higher than 
40% by Amayo et al.9 Availability of analgesics, as 
mentioned by Amayo et al,9 was the main factor for 
not consulting a physician.  In this study, 72% of 
patients visited a specialist at the onset. Inappropriate 
referrals to specialists in addition to wasting their 
time for screening - a process for which GPs are 
trained - enforce useless costs to the health system of 
the country. 
Evaluating the function of GPs may justify the 
patients  ʼ preference in visiting specialists. In our 
study, 69% of GPs were unable to diagnose migraine 
correctly, based on IHS criteria and consequently they 
prescribed wrong treatments. In patients with correct 
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diagnosis, only in 50% prophylactic treatments were 
prescribed on the basis of indications. This means 
that only 15% of GPs succeeded in correct diagnosis 
and prescribing drugs for the illness, which shows 
the unfamiliarity of a high percentage of them with 
migraine, diagnostic criteria and existing treatments. 
This was also mentioned by Shapero5 as one of the 
most important difficulties in migraine treatment.
The other aspect of the problem is the correct 
diagnosis of migraine only by 70% of the 
neurologists. This could be due to unavailability of 
effective referring system in Iran, which leads to the 
consultation of numerous patients and, consequently, 
lack of enough time for exact and complete evaluation 
of patients. Subsequently leading to the missing of 
many migraineurs with atypical headaches. It also 
shows that specifying more time for the patients, 
explaining the illness to them, the type of treatment 
and the need for probable drug changes, are effective 
both in drug compliance and follow up rates.13 It is 
obvious that these are among the duties of GPs who 
are bypassed by most patients in Iran.
In 21% of cases, propranolol was prescribed 
as a prophylaxis with a dosage of less than 20 mg 
daily, and there was only one incident of prescribing 
more than 60 mg daily. However, the least effective 
dosage for prophylaxis in clinical trials has been 20 
mg daily, which could be increased to 180 mg daily.1 
This indicates a caution by physicians in prescribing 
a higher dose; which causes inefficiency of most
treatments despite their correct diagnosis.
Regarding the unavailability of triptan compounds 
in Iran, the only available effective drugs on 5-
hydroxytryptamine (5-HT) receptors are Ergot 
Table 1 - Frequency of different drugs used as self-medication or prescribed by physicians for migraine attacks and prophylaxis*
Drug Patients consulting physician
N=103
Patients not consulting 
physician
 N=107
Pre-consulting
self-medication
N=82
Prescribed
drugs by physician
 N=81
Post-consulting
self-medication
N=57
Self-medication
N=99
A
N=82
P
N=4
A
N=81
P
N=52
A
N=57
P
N=0
A
N=99
P
N=1
   N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Acetaminophen 76 (93) - - 50  (62) - - 37 (65) - 92 (93) - -
Codeine 49 (60) 1 (25) 44  (54) - - 20  (35) - 71 (72) - -
NSAID 31  (38) - - 26  (32) 4 (8) 25  (44) - 39 (39) - -
Aspirin   7 (8) - - 2  (2) - - 3 (5) - 4 (4) - -
ACA  5  (7) - - 6  (7) 1 (2) 7 (12) - 4 (4) - -
TCA - - - - - - 28 (54) 2 (4) - 1 (1) - -
Beta blocker - - 3 (75) 2 (2) 42  (81) - - - - - 1 (100)
Ergotamine 4 (5) - - 21  (25) 1  (2) 1 (2) - 1 (1) - -
Belladonna - - - - - - 1  (2) - - - - - - -
Antidopaminergic - - - - - - 1 (2) - - - - - - -
Antihistamines 1  (1) - - - - - - 1 (2) - 1 (1) - -
Fluoxetine - - - - - - 6 (12) - - - - - - -
Sodium valporat - - - - 1 (1)    4 (8) - - - - - - -
Cyproheptadine - - - - 2  (2) 8 (15) - - - - - - -
Benzodiazepines 10 (12) - - 4  (5)   9  (17) 8  (14) - 5 (6) - -
Corticosteroids - - - - 2 (2) 1  (2) 1  (2) - - - - -
*Some of the patients had used more than one drug. A -  Attackʼs treatment, P - Prophylactic treatment, 
NSAID - Non-Steroidal Anti-Inflammatory Drug.  ACA - Acetaminophen, Caffeine, Aspirin, TCA - Tricyclic anti-depressant.
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compounds. In spite of their proven role in controlling 
migraine attacks, they have been prescribed only in 
21 cases and its consumption method was wrong in 
17 cases. Although the prescription of antiemetics, 
especially Metoclopramide, with Ergot compounds to 
reduce nausea has been emphasized in most studies 
and references,3 there was no such co-prescription. 
Codeine was prescribed in 44 cases, while its use for 
migraine treatment has been restricted2,3 to very severe 
and infrequent cases which do not respond to regular 
treatments. Frequent use of these compounds may lead 
to daily headaches caused by dependency, which are 
difficult to differentiate from migraine attacks.10  Most 
of the used medications in severe migraine attacks in 
our study were from the group of nonspecificanalgesics
and non-steroidal anti-inflammatory drugs, which are
considered as treatments of mild migraine.3 Nasal 
sprays, subcutaneous and intramuscular injections 
had not been used for any patient. In prophylaxis, 
except for beta blocker and TCA, other prophylactic 
compounds were not used or instances for their usage 
were much less than the expected rate, for example 
Sodium-Valproate was prescribed for only 4 patients 
(Table 1). This prescription method can be partly 
explained by the unavailability of newer drugs and 
compound medications or their high price in Iran.
 For the self-medication rate in this study (91.4%) 
was one of the highest compared to other studies such 
as MacGregor et al14 (42.3%) and Caro et al12 (51%). 
This high rate is probably due to drug availability 
without prescription in Iran, and improper diagnosis 
and treatment by physicians; and the latter could be 
the reason for the same rate of self-medication in the 
2 groups. 
In our study, alternative medicines were used a 
little less than that recorded by MacGregor et al,14 and 
methods such as yoga, hypnotherapy and acupuncture, 
which had proven effective on migraine,15-17 had not 
been used, or incorrectly used.
 In conclusion, improper function of physicians 
has led to the belief among a high percentage of 
migraineurs that migraine attacks are uncontrollable. 
Thus, revisions are inevitable and, to alleviate these 
problems, we must consider 3 points:1. Changing the 
education methods for raising physicians  ʼinformation 
and organizing re-education courses for them to 
get acquainted with new methods of diagnosis and 
treatment. 2. Changing drug consumption methods and 
limiting patients  ʼaccess to drugs without prescription 
and 3. Establishing a correct referral system.
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